Editorial to ‘A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients’

European Journal of Clinical InvestigationEarly View e14080 EDITORIAL Editorial to ‘A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients’ G. Porta, G. Porta Department of Emergency Medicine, Santa Maria Delle Grazie Hospital, Naples, ItalySearch for more papers by this authorJ. S. JohnBritto, J. S. JohnBritto Clinica Medica ‘A. Murri’, Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Bari, ItalySearch for more papers by this authorL. Bonfrate, Corresponding Author L. Bonfrate [email protected] orcid.org/0000-0002-4955-7964 Clinica Medica ‘A. Murri’, Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Bari, Italy Correspondence L. Bonfrate, Clinica Medica ‘A. Murri’ & Division Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Piazza G. Cesare 11, 70124 Bari, Italy. Email: [email protected]Search for more papers by this author G. Porta, G. Porta Department of Emergency Medicine, Santa Maria Delle Grazie Hospital, Naples, ItalySearch for more papers by this authorJ. S. JohnBritto, J. S. JohnBritto Clinica Medica ‘A. Murri’, Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Bari, ItalySearch for more papers by this authorL. Bonfrate, Corresponding Author L. Bonfrate [email protected] orcid.org/0000-0002-4955-7964 Clinica Medica ‘A. Murri’, Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Bari, Italy Correspondence L. Bonfrate, Clinica Medica ‘A. Murri’ & Division Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University ‘Aldo Moro’, Policlinico Hospital, Piazza G. Cesare 11, 70124 Bari, Italy. Email: [email protected]Search for more papers by this author First published: 22 August 2023 https://doi.org/10.1111/eci.14080Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis. 2014; 27(2): 174-183. 2El-Baba F, Gao Y, Soubani AO. Pulmonary aspergillosis: what the generalist needs to know. Am J Med. 2020; 133(6): 668-674. 3Ledoux MP, Herbrecht R. Invasive pulmonary aspergillosis. J Fungi (Basel). 2023; 9(2): 131. 4Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007; 44(10): 1289-1297. 5Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002; 347(6): 408-415. 6Palmieri F, Koutsokera A, Bernasconi E, Junier P, von Garnier C, Ubags N. Recent advances in fungal infections: from lung ecology to therapeutic strategies with a focus on Aspergillus spp. Front Med (Lausanne). 2022; 9:832510. 7Dimopoulos G, Frantzeskaki F, Poulakou G, Armaganidis A. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci. 2012; 1272: 31-39. 8Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004; 170(6): 621-625. 9Li W, Chen G, Lin F, et al. A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients. Eur J Clin Investig. 2023; 53(7):e13985. 10Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021; 21(6): e149-e162. 11Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis. 2021; 73(11): e3606-e3614. 12White PL, Dhillon R, Cordey A, et al. A National Strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021; 73(7): e1634-e1644. Early ViewOnline Version of Record before inclusion in an issuee14080 ReferencesRelatedInformation